Beste Mutlu

Beste Mutlu

Auto-generated profile, based on publicly available information

Beste Mutlu

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2011 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
MCMurat Cokol
Murat Cokol
HCHon Nian Chua
Hon Nian Chua
MTMurat Tasan
Murat Tasan
BMBeste Mutlu
Beste Mutlu
ZWZohar B Weinstein
Zohar B Weinstein
FRFrederick Roth
Frederick Roth
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

3 August 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
BMBeste Mutlu
Beste Mutlu
HCHuei-Mei Chen
Huei-Mei Chen
JMJames Moresco
James Moresco
BOBarbara D. Orelo
Barbara D. Orelo
BYBing Yang
Bing Yang
SMSusan E. Mango
Susan E. Mango
Heterochromatin formation during early embryogenesis is timed precisely, but how this process is regulated remains elusive. We report the discovery of a histone methyltransferase complex whose nuclear accumulation and activation establish the onset of heterochromatin formation in Caenorhabditis elegans embryos. We find that the inception of heterochromatin generation coincides with the accumulation of the histone H3 lysine 9 (H3K9) methyltransferase MET-2 (SETDB) into nuclear hubs. The absence of MET-2 results in delayed and disturbed heterochromatin formation, whereas accelerated nuclear localization of the methyltransferase leads to precocious H3K9 methylation. We identify two factors that bind to and function with MET-2: LIN-65, which resembles activating transcription factor 7–interacting protein (ATF7IP) and localizes MET-2 into nuclear hubs, and ARLE-14, which is orthologous to adenosine 5′-diphosphate–ribosylation factor-like 14 effector protein (ARL14EP) and promotes stable association of MET-2 with chromatin. These data reveal that nuclear accumulation of MET-2 in conjunction with LIN-65 and ARLE-14 regulates timing of heterochromatin domains during embryogenesis.

19 August 2020 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
BMBeste Mutlu
Beste Mutlu
PPPere Puigserver
Pere Puigserver

26 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CTClint D. J. Tavares
Clint D. J. Tavares
SAStefan Aigner
Stefan Aigner
KSKfir Sharabi
Kfir Sharabi
SSShashank Sathe
Shashank Sathe
BMBeste Mutlu
Beste Mutlu
PPPere Puigserver
Pere Puigserver
The peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a transcriptional coactivator that controls expression of metabolic/energetic genes, programming cellular responses to nutrient and environmental adaptations such as fasting, cold, or exercise. Unlike other coactivators, PGC-1α contains protein domains involved in RNA regulation such as serine/arginine (SR) and RNA recognition motifs (RRMs). However, the RNA targets of PGC-1α and how they pertain to metabolism are unknown. To address this, we performed enhanced ultraviolet (UV) cross-linking and immunoprecipitation followed by sequencing (eCLIP-seq) in primary hepatocytes induced with glucagon. A large fraction of RNAs bound to PGC-1α were intronic sequences of genes involved in transcriptional, signaling, or metabolic function linked to glucagon and fasting responses, but were not the canonical direct transcriptional PGC-1α targets such as OXPHOS or gluconeogenic genes. Among the top-scoring RNA sequences bound to PGC-1α were Foxo1, Camk1δ, Per1, Klf15, Pln4, Cluh, Trpc5, Gfra1, and Slc25a25. PGC-1α depletion decreased a fraction of these glucagon-induced messenger RNA (mRNA) transcript levels. Importantly, knockdown of several of these genes affected glucagon-dependent glucose production, a PGC-1α–regulated metabolic pathway. These studies show that PGC-1α binds to intronic RNA sequences, some of them controlling transcript levels associated with glucagon action. Significance Glucagon action in liver is a central response to fasting and type 2 diabetes. Glucagon action has been delineated through regulatory mechanisms involving signaling, transcription factor/coactivator-based gluconeogenic gene expression, and metabolic enzyme activity. Understanding the molecular mechanisms whereby glucagon controls energy metabolism will define new strategies and potential therapies to treat metabolic diseases. Here, we have identified a regulatory mechanism whereby PGC-1α, a known transcriptional regulator of glucagon action, binds RNAs linked to glucose energy metabolism. PGC-1α represents a class of RNA-binding proteins that act as a transcriptional coactivator through transcription factor binding, but also binds to RNA sequences to control specific mRNA transcripts encoding for metabolic and bioenergetic genes.

1 October 2019 in Development
Verified
Journal Article
Closed access
PDF file
BMBeste Mutlu
Beste Mutlu
HCHuei-Mei Chen
Huei-Mei Chen
SGSilvia Gutnik
Silvia Gutnik
DHDavid H. Hall
David H. Hall
SKSabine Keppler-Ross
Sabine Keppler-Ross
SMSusan E. Mango
Susan E. Mango
During the first hours of embryogenesis, formation of higher-order heterochromatin coincides with the loss of developmental potential. Here, we examine the relationship between these two events, and we probe the processes that contribute to the timing of their onset. Mutations that disrupt histone H3 lysine 9 (H3K9) methyltransferases reveal that the methyltransferase MET-2 helps terminate developmental plasticity, through mono- and di-methylation of H3K9 (me1/me2), and promotes heterochromatin formation, through H3K9me3. Although loss of H3K9me3 perturbs formation of higher-order heterochromatin, embryos are still able to terminate plasticity, indicating that the two processes can be uncoupled. Methylated H3K9 appears gradually in developing C. elegans embryos and depends on nuclear localization of MET-2. We find that the timing of H3K9me2 and nuclear MET-2 is sensitive to rapid cell cycles, but not to zygotic genome activation or cell counting. These data reveal distinct roles for different H3K9 methylation states in the generation of heterochromatin and loss of developmental plasticity by MET-2, and identify the cell cycle as a crucial parameter of MET-2 regulation.

1 April 2014 in Chemistry & Biology
Verified
Journal Article
Closed access
MCMurat Cokol
Murat Cokol
ZWZohar B. Weinstein
Zohar B. Weinstein
KYKaan Yilancioglu
Kaan Yilancioglu
MTMurat Tasan
Murat Tasan
ADAllison Doak
Allison Doak
FRFrederick Roth
Frederick Roth